Insulin detemir

This classification denotes a therapeutic insulin with the molecular formula C267H402N64O76S6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4FT78T86XV, chemically known as insulin (ox), 8a-l-threonine-10a-l-isoleucine-30b-l-threonine- but more generally known as insulin, which bears US NIH Compound Identifier 16129672. European Medicines Agency schedules Insulin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB02689MIG. The term INSULIN DETEMIR is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 13 No. 3, 1999, List 42) WHO schedules insulin in its Anatomical Therapeutic Chemical (ATC) Classification. INSULIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule insulin detemir under HS 29349990 and SITC 51579. Insulin detemir bears US NLM identifiers UMLS ID C0537270 and NCI Concept Code C65920. SMILES: As of Q4 2014, INSULIN DETEMIR remains US FDA's Preferred Term for this commodity.